Intensive Care Medicine

, Volume 45, Issue 4, pp 501–504 | Cite as

Does this critically ill patient with delirium require any drug treatment?

  • Jorge I. F. SalluhEmail author
  • Nicola Latronico
What's New in Intensive Care

Delirium is a severe and frequent condition that occurs in 20–40% of patients admitted to the intensive care unit (ICU), with higher rates of 60–80% described in mechanically ventilated patients. The accumulated evidence in the past decades demonstrates that delirium is clearly associated with hospital mortality, lengths of stay, duration of mechanical ventilation and costs [1, 2]. Moreover, the presence of delirium and its duration and severity are risk factors for long-term cognitive impairment in patients surviving critical illness [1]. Although agitated (hyperactive) delirium attracts the intensivist's attention and frequently requires interventions to prevent self-harm and control the symptoms, the hypoactive and mixed forms are extremely common and frequently associated with poor outcomes. However, to correctly diagnose patients with delirium regardless of its presentation form, it is mandatory to use valid and reproducible screening tools such as the Confusion Assessment Method...



Dr. Salluh is supported in part by an individual research grant from CNPq and FAPERJ.

Compliance with ethical standards

Conflicts of interest

All authors declare that they have no conflict of interest.

Supplementary material

134_2018_5310_MOESM1_ESM.docx (29 kb)
Supplementary material 1 (DOCX 28 kb)


  1. 1.
    Salluh JI, Wang H, Schneider EB et al (2015) Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ. Google Scholar
  2. 2.
    Khan BA, Perkins AJ, Gao S et al (2017) The confusion assessment method for the ICU-7 Delirium Severity Scale. Crit Care Med. Google Scholar
  3. 3.
    Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary. Am J Health Syst Pharm. Google Scholar
  4. 4.
    Morandi A, Piva S, Ely EW et al (2017) Worldwide survey of the “Assessing Pain, Both Spontaneous Awakening and Breathing Trials, Choice of Drugs, Delirium Monitoring/Management, Early Exercise/Mobility, and Family Empowerment” (ABCDEF) Bundle. Crit Care Med. Google Scholar
  5. 5.
    Cavalcanti AB, Bozza FA, Machado FR et al (2016) Effect of a quality improvement intervention with daily round checklists, goal setting, and clinician prompting on mortality of critically ill patients: a randomized clinical trial. JAMA J Am Med Assoc. Google Scholar
  6. 6.
    Barnes-Daly MA, Phillips G, Ely EW (2017) Improving hospital survival and reducing brain dysfunction at seven california community hospitals. Crit Care Med. Google Scholar
  7. 7.
    Rosa RG, Tonietto TF, Da Silva DB et al (2017) Effectiveness and safety of an extended icu visitation model for delirium prevention: a before and after study. Crit Care Med. Google Scholar
  8. 8.
    Serafim RB, Bozza FA, Soares M et al (2015) Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review. J Crit Care. Google Scholar
  9. 9.
    Neufeld KJ, Yue J, Robinson TN et al (2016) Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis. J Am Geriatr Soc. Google Scholar
  10. 10.
    van den Boogaard M, Slooter AJC, Brüggemann RJM et al (2018) Effect of haloperidol on survival among critically ill adults with a high risk of delirium. JAMA. Google Scholar
  11. 11.
    Delaney A, Hammond N, Litton E (2018) Preventing delirium in the intensive care unit. JAMA. Google Scholar
  12. 12.
    Oh ES, Fong TG, Hshieh TT, Inouye SK (2017) Delirium in older persons. JAMA. Google Scholar
  13. 13.
    Skrobik Y, Duprey MS, Hill NS, Devlin JW (2018) Low-dose nocturnal dexmedetomidine prevents ICU delirium: a randomized, placebo-controlled trial. Am J Respir Crit Care Med.
  14. 14.
    Wassenaar A, van den Boogaard M, van Achterberg T et al (2015) Multinational development and validation of an early prediction model for delirium in ICU patients. Intensive Care Med. Google Scholar
  15. 15.
    Chevrolet JC, Jolliet P (2007) Clinical review: Agitation and delirium in the critically ill—significance and management. Crit Care 11(3):214CrossRefGoogle Scholar
  16. 16.
    Reade MC, Eastwood GM, Bellomo R et al (2016) Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium a randomized clinical trial. JAMA J Am Med Assoc. Google Scholar
  17. 17.
    Latronico N (2018) Haloperidol and delirium in the ICU: the finger pointing to the moon. Intensive Care Med. Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature and ESICM 2018

Authors and Affiliations

  1. 1.D’Or Institute for Research and EducationRio de JaneiroBrazil
  2. 2.Programa de Pós-Graduação em Clinica médicaUniversidade Federal do Rio de JaneiroRio de JaneiroBrazil
  3. 3.Department of Medical and Surgical Specialties, Radiological Sciences and Public HealthUniversity of BresciaBresciaItaly
  4. 4.Department of Anesthesia, Critical Care and EmergencySpedali Civili University HospitalBresciaItaly

Personalised recommendations